文献速递脊柱关节炎

强直性脊柱炎相关RUNX3多态性的功能基因组学分析

Functional Genomic Analysis of a RUNX3 Polymorphism Associated With Ankylosing Spondylitis.
PubMed 文献 · Arthritis Rheumatol · 2021-05-02

该研究探讨强直性脊柱炎(AS)易感位点rs4648889(位于RUNX3启动子上游的疑似增强子区)的功能后果。利用Jurkat细胞和原代人CD8+ T细胞的核提取物,通过DNA pull-down联合定量质谱、EMSA、Western blot和ChIP-qPCR验证等位基因特异性转录因子结合,并用siRNA敲低IRF5后检测IFNγ表达。结果显示AS风险等位基因A对IKZF3、CHD4和RBBP4的结合增强,而保护等位基因G对IRF5的结合显著增强;沉默IRF5可增加CD8+ T细胞中IFNγ mRNA和蛋白水平。

要点

  • rs4648889风险等位基因A增强IKZF3、CHD4和RBBP4等转录因子结合。
  • 保护等位基因G对IRF5的结合显著强于风险等位基因A。
  • 沉默IRF5可升高CD8+ T细胞中IFNγ的mRNA和蛋白水平。

核心结论

  • rs4648889与AS的关联可能反映了该增强子样区域与IRF5、IKZF3及NuRD复合物成员等转录因子的等位基因特异性结合。
  • IRF5可能对CD8+淋巴细胞功能有重要影响,并可能为AS管理提供新治疗靶点。

研究设计与样本

  • 使用Jurkat细胞和原代人CD8+ T细胞的核提取物进行功能研究。
  • 通过DNA pull-down联合定量质谱检测rs4648889的等位基因特异性转录因子结合,并用EMSA、Western blot和ChIP-qPCR验证。
  • 通过siRNA敲低IRF5,再用RT-qPCR和ELISA分别检测IFNγ mRNA和蛋白水平。

主要发现

  • 在CD8+ T细胞核提取物中,AS风险等位基因A对IKZF3(Aiolos)的相对转录因子结合增加3.7倍(P < 0.03)。
  • AS风险等位基因A对NuRD复合物组分CHD4的结合增加3.6倍(P < 0.05),对RBBP4的结合增加4.1倍(P < 0.03)。
  • IRF5对AS保护等位基因G的结合显著多于风险等位基因A(倍数变化8.2;P = 0.003)。
  • Western blot、EMSA和ChIP-qPCR验证了IKZF3、CHD4、RBBP4和IRF5的差异等位基因结合。
  • 在CD8+ T细胞中沉默IRF5后,RT-qPCR检测的IFNγ mRNA水平升高(P = 0.03),ELISA检测的IFNγ蛋白水平升高(P = 0.02)。

临床怎么用

  • 本研究为机制探索,尚未提供可直接用于临床决策的推荐或阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the functional consequences of the single-nucleotide polymorphism rs4648889 in a putative enhancer upstream of the RUNX3 promoter associated with susceptibility to ankylosing spondylitis (AS). METHODS: Using nuclear extracts from Jurkat cells and primary human CD8+ T cells, the effects of rs4648889 on allele-specific transcription factor (TF) binding were investigated by DNA pull-down assay and quantitative mass spectrometry (qMS), with validation by electrophoretic mobility shift assay (EMSA), Western blotting of the pulled-down eluates, and chromatin immunoprecipitation (ChIP)-quantitative polymerase chain reaction (qPCR) analysis. Further functional effects were tested by small interfering RNA knockdown of the gene for interferon regulatory factor 5 (IRF5), followed by reverse transcription-qPCR (RT-qPCR) and enzyme-linked immunosorbent assay (ELISA) to measure the levels of IFNγ messenger RNA (mRNA) and protein, respectively. RESULTS: In nuclear extracts from CD8+ T cells, results of qMS showed that relative TF binding to the AS-risk A allele of rs4648889 was increased 3.7-fold (P < 0.03) for Ikaros family zinc-finger protein 3 (IKZF3; Aiolos) and components of the NuRD complex, including chromodomain helicase DNA binding protein 4 (CHD4) (3.6-fold increase; P < 0.05) and retinoblastoma binding protein 4 (RBBP4) (4.1-fold increase; P < 0.03). In contrast, IRF5 bound significantly more to the AS-protective G allele compared to the AS-risk A allele (fold change 8.2; P = 0.003). Validation with Western blotting, EMSA, and ChIP-qPCR confirmed the differential allelic binding of IKZF3, CHD4, RBBP4, and IRF5. Silencing of IRF5 in CD8+ T cells increased the levels of IFNγ mRNA as measured by RT-qPCR (P = 0.03) and IFNγ protein as measured by ELISA (P = 0.02). CONCLUSION: These findings suggest that the association of rs4648889 with AS reflects allele-specific binding of this enhancer-like region to certain TFs, including IRF5, IKZF3, and members of the NuRD complex. IRF5 may have crucial influences on the functions of CD8+ lymphocytes, a finding that could reveal new therapeutic targets for the management of AS.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Vecellio M, Chen L, Cohen CJ, et al. Functional Genomic Analysis of a RUNX3 Polymorphism Associated With Ankylosing Spondylitis. Arthritis Rheumatol. 2021. PMID: 33369221. doi:10.1002/art.41628

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。